Chairman Of The Board
Sanare Pharmaceuticals Corp
AeroLeads people directory · profile
Ivor Royston Email & Phone Number
Chairman of the Board
at
Sanare Pharmaceuticals Corp
1 work email found
@viracta.com
6 phones found area 858
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Sanare Pharmaceuticals Corp
Role
Chairman of the Board
Location
San Diego, California, United States
Who is Ivor Royston? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Ivor Royston is listed as Chairman of the Board at Sanare Pharmaceuticals Corp, based in San Diego, California, United States. AeroLeads shows a work email signal at viracta.com, phone signal with area code 858, and a matched LinkedIn profile for Ivor Royston.
Ivor Royston previously worked as Executive Chairman at Geneditor Biologics Corp. and Non-executive Member Board of Directors at Viracta Therapeutics, Inc., A Nasdaq Listed Biotech Company [Virx]. Ivor Royston holds Md, Medicine from The Johns Hopkins University School Of Medicine.
Company email context
Email format at Sanare Pharmaceuticals Corp
This section adds company-level context without repeating Ivor Royston's masked contact details.
{first_initial}{last}@viracta.com
86% confidence
AeroLeads found 1 current-domain work email signal for Ivor Royston. Compare company email patterns before reaching out.
Profile bio
About Ivor Royston
BiopharmaceuticalMedical Oncology
Listed skills include Venture Capital, Lifesciences, Biotechnology, Start Ups, and 26 others.
Current workplace
Ivor Royston's current company
Company context helps verify the profile and gives searchers a useful next step.
Sanare Pharmaceuticals Corp
14 roles · 25 years
Ivor Royston work experience
A career timeline built from the work history available for this profile.
Executive Chairman
Current
Geneditor Biologics Corp.
Apr 2023 - Present
Non-Executive Member Board Of Directors
Current
Viracta Therapeutics, Inc., A Nasdaq Listed Biotech Company [Virx]
Member of the Science & Technology Committee
Sep 2022 - Present
President, Ceo, Founder, And Executive Board Member
Viracta Therapeutics, Inc., A Nasdaq Listed Biotech Company [Virx]
Viracta Therapeutics is a public clinical stage oncology company focused on novel therapies for virus-associated cancers. The lead program is based on a novel targeted therapy with an oral combination drug product, termed NanaVal for cancers containing the genome of the Epstein-Barr Virus (EBV). NanaVal is currently being studied in a late-stage pivotal.
Dec 2014 - Sep 2022
Member Board Of Directors
Current
Biocept, Inc. - Personalized Medicine From A Liquid Biopsy, A Nasdaq Listed Company [Bioc]
Biocept is a liquid biopsy company that detects and analyzes both circulating tumor cells and cell free DNA in the blood and bodily fluids, such as cerebrospinal fluid to detect and analyze cancer cells
Jul 2010 - Present
Member Board Of Directors
Syndax Pharmaceuticals - A Nasdaq Listed Biotech Company [Sndx]
Served on the Nomination & Governance Committee, and Science & Technology Committee
Jul 2010 - Mar 2017
Founding Managing Partner
Forward Ventures , A Specialized Life Science Venture Capital Fund
Forward Ventures had 5 consecutive LP funds with over $400 million under management. The Fund specialized in early company formation and development in the life sciences.
Jul 1990 - Mar 2017
Chairman Of The Board Of Directors
Targegen was a targeted therapy company that developed the drug fedratinib for treating myelofibrosis. Aquired by Sanofi. Later restructured as Impact Bioscience and then aquired by Celgene/BMS
Jul 2002 - Oct 2010
Chairman Of The Board Of Directors
Ligocyte Pharmaceuticals, Inc. (Aquired By Takeda)
Ligocyte completed development of a norovirus vaccine, and company acquired by Takeda.
Apr 2006 - Apr 2010
Chairman Of The Board Of Directors
Morphotek - Acquired By Eisai, Inc
Improved monoclonal antibody clinical development to novel cancer cell targets. Intimately involved in sale of company to Eisai.
Apr 2004 - Jun 2007
Chairman Of The Board Of Directors
Cancervax, Inc, Nasdaq Listed Biotech Company,
Cancer vaccine company which merged with Micromet, Inc. and later aquired by Amgen
2001 - 2006
~5 yrs
President, Ceo, Founder,Board Member
Non-profit cancer research institute
Jul 1990 - Jun 2000
Founder, Consultant, Board Member
Idec, Inc - Nasdaq Listed Company [Idec]
IDEC developed the first monoclonal antibody, Rituxan, for lymphoma approved by FDA - now standard of care. IDEC later merged with Biogen in 2003/
Jul 1985 - Jun 1992
Founder, Consultant, Board Member
Hybritech Incorporated A Nasdaq Listed Company [Hybr]
Hybritech was the first biotechnology company in the San Diego area. It pioneered the development of monoclonal antibodies for diagnostic use and developed the PSA test for prostate cancer, which became standard of care for the early diagnosis and monitoring of prostate cancer. Hybritech was acquired by Lilly in 1986.
Apr 1978 - Jun 1986
3 education records
Ivor Royston education
Md, Medicine
The Johns Hopkins University School Of Medicine
Bachelor Of Arts - Ba, Human Biology
The Johns Hopkins University
Education record
The George Washington University
FAQ
Frequently asked questions about Ivor Royston
Quick answers generated from the profile data available on this page.
What company does Ivor Royston work for?
Ivor Royston works for Sanare Pharmaceuticals Corp.
What is Ivor Royston's role at Sanare Pharmaceuticals Corp?
Ivor Royston is listed as Chairman of the Board at Sanare Pharmaceuticals Corp.
What is Ivor Royston's email address?
AeroLeads has found 1 work email signal at @viracta.com for Ivor Royston at Sanare Pharmaceuticals Corp.
What is Ivor Royston's phone number?
AeroLeads has found 6 phone signal(s) with area code 858 for Ivor Royston at Sanare Pharmaceuticals Corp.
Where is Ivor Royston based?
Ivor Royston is based in San Diego, California, United States while working with Sanare Pharmaceuticals Corp.
What companies has Ivor Royston worked for?
Ivor Royston has worked for Sanare Pharmaceuticals Corp, Geneditor Biologics Corp., Viracta Therapeutics, Inc., A Nasdaq Listed Biotech Company [Virx], Biocept, Inc. - Personalized Medicine From A Liquid Biopsy, A Nasdaq Listed Company [Bioc], and Syndax Pharmaceuticals - A Nasdaq Listed Biotech Company [Sndx].
How can I contact Ivor Royston?
You can use AeroLeads to view verified contact signals for Ivor Royston at Sanare Pharmaceuticals Corp, including work email, phone, and LinkedIn data when available.
What schools did Ivor Royston attend?
Ivor Royston holds Md, Medicine from The Johns Hopkins University School Of Medicine.
What skills is Ivor Royston known for?
Ivor Royston is listed with skills including Venture Capital, Lifesciences, Biotechnology, Start Ups, Biopharmaceuticals, Oncology, Commercialization, and Pharmaceutical Industry.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial